Researchers found that the vaccine effectiveness against hospitalization remained high at 78%, four months after the third dose.
Long COVID symptoms can include pain, fatigue and brain fog weeks or months after the initial infection.
During this early look at the performance of the booster, researchers found that the vaccine effectiveness against hospitalization remained high at 78%, four months after the third dose. Dr. Maria Raven, Chief of Emergency Medicine at UCSF has noticed the difference in patients. Dr. Gandhi:"I don't think that as a general population we will, but I think certain groups always will. Immunocompromised already approved for fourth booster and I think older people depending on how much COVID is circulating."
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more: